The coronavirus (COVID-19) pandemic has overwhelmed most health services. As a result, many surgeries have been deferred and diagnoses delayed. The aim of this study was to assess the effect of the COVID-19 pandemic at a high-volume pelvic oncology centre.
Methods:
A retrospective review was performed of clinical activity from 2017 to 2020. We compared caseload for index procedures 2017–2019 (period 1) versus 2020 (period 2) to see the effect of the COVID pandemic. We then compared the activity during the first lockdown (March 23rd) to the rest of the year when we increased our theatre access by utilising a ‘clean’ site.
Results:
The average annual number of robotic assisted radical cystectomy (RARC) and robotic assisted radical prostatectomy (RARP) performed during period 1 was 82 and 352 respectively. This reduced to 68 (17.1% reduction) and 262 (25.6% reduction) during period 2. The number of patients who underwent prostate brachytherapy decreased from 308 to 243 (21% reduction). The number of prostate biopsies decreased from 420 to 234 (44.3% reduction). The number of radical orchidectomies decreased from 18 to 11 (39% reduction). The mean number of RARC and RARP per month during period 2 was 5.5 and 22. This decreased to 4 and 9 per month during the first national lockdown but was maintained thereafter despite two further lockdowns.
Conclusion:
There has been a substantial decrease in urological oncology caseload during the COVID pandemic. The use of alternate pathways such as ‘clean’ sites can ensure continuity of care for cancer surgery and training needs.
HeldweinFLLoebSWroclawskiML, et al. A systematic review on guidelines and recommendations for urology standard of care during the COVID-19 pandemic. Eur Urol Focus2020; 6(5): 1070–1085.
CarneiroAWroclawskiMLNaharB, et al. Impact of the COVID-19 pandemic on the urologist’s clinical practice in Brazil: a management guideline proposal for low- and middle-income countries during the crisis period. Int Braz J Urol2020; 46: 501–510.
9.
KwonYSTabakinALPatelHV, et al. Adapting urology residency training in the COVID-19 Era. Urology2020; 141: 15–19.
10.
WestermanMETabakinALSextonWJ, et al. Impact of CoVID-19 on resident and fellow education: current guidance and future opportunities for urologic oncology training programs. Urol Oncol2021; 39: 357–364.
11.
RosenGHMurrayKSGreeneKL, et al. Effect of COVID-19 on urology residency training: a nationwide survey of program directors by the Society of Academic Urologists. J Urol2020; 204(5): 1039–1045.
12.
ThomasAADerboghossiansAChangA, et al. Impact of trainee involvement with robotic-assisted radical prostatectomy. J Robot Surg2013; 7(3): 289–293.
13.
KheneZEPeyronnetBBosquetE, et al. Does training of fellows affect peri-operative outcomes of robot-assisted partial nephrectomy?BJU Int2017; 120(4): 591–599.
CampiRAmparoreDCapitanioU, et al. Assessing the burden of nondeferrable major uro-oncologic surgery to guide prioritisation strategies during the COVID-19 pandemic: insights from three Italian high-volume referral centres. Eur Urol2020; 78(1): 11–15.
16.
AmparoreDCampiRCheccucciE, et al. Forecasting the future of urology practice: a comprehensive review of the recommendations by International and European Associations on priority procedures during the COVID-19 pandemic. Eur Urol Focus2020; 6(5): 1032–1048.
17.
CohnJAGhiraldiEMUzzoRG, et al. A critical appraisal of the American College of Surgeons medically necessary, time sensitive procedures (MeNTS) scoring system, urology consensus recommendations and individual surgeon case prioritization for resumption of elective urological surgery during the COVID-19 pandemic. J Urol2021; 205(1): 241–247.
18.
KulkarniGSUrbachDRAustinPC, et al. Longer wait times increase overall mortality in patients with bladder cancer. J Urol2009; 182(4): 1318–1324.
19.
EnglTMandelPHoehB, et al. Impact of “Time-From-Biopsy-to-Prostatectomy” on adverse oncological results in patients with intermediate and high-risk prostate cancer. Front Surg2020; 7: 561853.
20.
XiaLTalwarRChelluriRR, et al. Surgical delay and pathological outcomes for clinically localized high-risk prostate cancer. JAMA Network Open2020; 3(12): e2028320.
21.
DiamandRPloussardGRoumiguiéM, et al. Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic. World J Urol2021; 39: 1789–1796.
22.
GinsburgKBCurtisGLTimarRE, et al. Delayed radical prostatectomy is not associated with adverse oncologic outcomes: implications for men experiencing surgical delay due to the COVID-19 pandemic. J Urol2020; 204(4): 720–725.
23.
CampiRTelliniRGrossoAA, et al. Deferring elective urologic surgery during the COVID-19 pandemic: the patients’ perspective. Urology2021; 147: 21–26.
24.
JewettMRendonRDranitsarisG, et al. Does prolonging the time to renal cancer surgery affect long-term cancer control: a systematic review of the literature. J Urol2006; 13(Suppl 3): 54–61.
25.
SaadFFinelliADranitsarisG, et al. Does prolonging the time to prostate cancer surgery impact long-term cancer control: a systematic review of the literature. J Urol2006; 13(Suppl 3): 16–24.
26.
FleshnerNDranitsarisGFinelliA, et al. Surgical wait times for patients with urological cancers: a survey of Canadian surgeons. Can J Urol2006; 13(Suppl 3): 3–13.
27.
BellDMorashCDranitsarisG, et al. Does prolonging the time to testicular cancer surgery impact long-term cancer control: a systematic review of the literature. Can J Urol2006; 13(Suppl 3): 30–36.
28.
ColemanJRAbdelsattarJMGlockerRJ.COVID-19 pandemic and the lived experience of surgical residents, fellows, and early-career surgeons in the American College of Surgeons. J Am Coll Surg2021; 232(2): 119–135.e20.
29.
TanWSArianayagamRKhetrapalP, et al. Major urological cancer surgery for patients is safe and surgical training should be encouraged during the COVID-19 pandemic: a multicentre analysis of 30-day outcomes. Eur Urol Open Sci2021; 25: 39–43.
30.
BolgerJCKellyMEWhelanC, et al. Public-private partnership: strategies for continuing urgent elective operative care during the COVID-19 pandemic. Br J Surg2020; 107(9): e320–e321.
31.
RoccoBBagniABertelliniE, et al. Planning of surgical activity in the COVID-19 era: a proposal for a step toward a possible healthcare organization. Urologia2020; 87(4): 175–177.
